Delivery Order SPE2DB20D9103-SPE2DB23FE7D0
Award Date
6/8/23
Potential Completion Date
6/9/23
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $15,143.20 firm fixed-price delivery order is for the supply of Nucala 100 mg/mL auto-injectors. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which provides a wide range of pharmaceutical products and medical supplies to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $11,357.40 with a firm fixed-price pricing type. The contract was awarded by the Defense Logistics Agency (DLA) to provide Nucala 100 mg/mL auto-injectors. The award is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $499,999,999 that allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,785.80 firm fixed-price delivery order is for Nucala 100 mg/mL auto-injectors. This is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a wide range of pharmaceutical products, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,892.90 firm fixed-price delivery order is for the provision of Nucala 100 mg/mL auto-injectors to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $3,785.80 for the provision of Nucala 100 mg/ml auto-injectors. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of January 12, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. It is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,892.90 firm fixed-price delivery order is for the supply of Nucala 100 mg/mL auto-injectors to support the recurring medical needs of military health facilities worldwide. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $11,357.40 for the supply of Nucala 100 mg/mL auto-injectors. The contract is issued by the Defense Logistics Agency (DLA), a defense agency, and is not associated with any set-aside designation. The contract is a firm fixed-price delivery order awarded under a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,892.90 firm fixed-price delivery order is for the supply of Nucala 100 mg/ml auto-injector medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,785.80 firm fixed-price delivery order is for the supply of Nucala 100 mg/mL auto-injectors. The contract has an ultimate completion date of December 13, 2024 and is not associated with any set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,892.90 firm fixed-price contract is for the delivery of Nucala 100 mg/ml auto-injectors to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...